As with cancer and HIV infections, progress in treatment for the genetic disorder cystic fibrosis has come with ever-more sophisticated cocktails of drugs.
Vice President for Corporate Engagement, Rose-Hulman Institute of Technology
Founder and Chairman, Sycamore Networks
Partner at New Enterprise Associates
Director, Life Sciences Institute, University of Michigan
Ben Einstein, co-founder and general partner of hardware-focused investor Bolt, says he has left the venture capital firm he started as his partner, Grace, enters chemotherapy for a cancer diagnosis.
“Through this gut-wrenching experience, the things I enjoy doing and that... Read more »
Turning Point Therapeutics, which is developing targeted cancer drugs for patients whose tumors resist other precision therapies, has outlined plans for an IPO.
The company, which started operations in 2014, has raised nearly $148 million since inception. It is headed by... Read more »
Let’s catch up with the latest innovation news in Texas.
—Georgetown, TX-based AgileCraft was acquired by Australia-based Atlassian (NASDAQ: TEAM), the team collaboration and productivity software maker, for $166 million. AgileCraft makes planning software that helps executives build and... Read more »
In 2007, Zach Wigal and his friends at Saline High School decided to organize one of Southeast Michigan’s first competitive video game tournaments. They spent months preparing and eventually arranged to rent out the school’s cafeteria. Everything seemed to be in... Read more »
Two young San Francisco companies on Wednesday announced fundraisings to bolster their online services aimed at improving workforce efficiency.
A decade ago, Kevin Conroy took the CEO job at Exact Sciences, a cancer diagnostic firm on the brink of death. Five years later, the FDA greenlit the company’s first product, Cologuard, which marked the first non-invasive, stool-based DNA... Read more »
Computer chipmaker Intel and its subcontractor, Seattle-based Cray, say they expect a supercomputer they plan to eventually deliver will be a flop—an exaflop, that is.
The FDA has just made brexanolone (Zulresso) the first medicine approved specifically for post-partum depression, a potentially devastating disorder that afflicts roughly one in every seven new mothers in the U.S., according to the American Psychological Association
Now the drug’s owner,... Read more »
Urovant Sciences says its experimental drug for overactive bladder could offer advantages compared to an FDA-approved treatment marketed by Astellas Pharma. But late-stage clinical results released Tuesday raise questions whether Urovant can persuade doctors to prescribe it instead of a much... Read more »
Flipside Crypto, a Boston startup developing analytics for cryptocurrencies, has landed its main metric onto CoinMarketCap and other financial websites including MarketWatch, TheStreet and Stocktwits, the company says.
Founded in 2017, Flipside says its Fundamental Crypto Asset Score—FCAS for short—rates the... Read more »
Dallas—AmplifAI Solutions, which makes artificial intelligence-enabled software for call center operations, has raised $3.9 million.
Investors in the funding round were Dallas-based Naya Ventures, and LiveOak Venture Partners and Capital Factory, both in Austin.
AmplifAI has developed software that uses... Read more »